Skip to main content
Clinical Trials/NCT06023667
NCT06023667
Completed
Not Applicable

Self-Management Assistance for Recommended Treatement (SMART) App Randomized Control Trial

Children's Hospital Medical Center, Cincinnati1 site in 1 country45 target enrollmentDecember 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammatory Bowel Diseases
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
45
Locations
1
Primary Endpoint
Medication adherence
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare a sample of 20 youth (ages 13-17) with IBD using an app that has educational content and medication reminders to 20 youth in an attention control group. The length of the intervention will include one month of baseline adherence data collection, one month of intervention, and one month of post-treatment adherence data collection.

Registry
clinicaltrials.gov
Start Date
December 14, 2022
End Date
December 28, 2023
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively IBD)
  • Prescribed at least one medication used to treat IBD, regardless of route of administration
  • Access to internet or wi-fi or data plan and access to smartphone
  • English fluency for patient and clinician

Exclusion Criteria

  • Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
  • Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review

Outcomes

Primary Outcomes

Medication adherence

Time Frame: 3 months

Medication adherence will be measured using electronic monitoring of medications indicated being taken in the SMART-IBD app

Study Sites (1)

Loading locations...

Similar Trials